Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,273 | 288 | 98.1% |
| Grant | $100.00 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,636 | 178 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $339.02 | 16 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $310.47 | 13 | $0 (2024) |
| Boston Scientific Corporation | $284.32 | 5 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $226.35 | 11 | $0 (2024) |
| Medtronic, Inc. | $198.80 | 2 | $0 (2024) |
| Synergy Pharmaceuticals Inc | $142.67 | 10 | $0 (2018) |
| Novo Nordisk Inc | $124.15 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $122.86 | 5 | $0 (2024) |
| Madrigal Pharmaceuticals | $109.75 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,851 | 76 | ABBVIE INC. ($599.39) |
| 2023 | $959.27 | 54 | AbbVie Inc. ($435.47) |
| 2022 | $609.85 | 44 | ABBVIE INC. ($383.63) |
| 2021 | $189.70 | 19 | AbbVie Inc. ($152.73) |
| 2020 | $111.82 | 7 | AbbVie Inc. ($99.80) |
| 2019 | $562.08 | 25 | AbbVie, Inc. ($200.67) |
| 2018 | $582.73 | 34 | AbbVie, Inc. ($370.03) |
| 2017 | $506.48 | 30 | AbbVie, Inc. ($394.57) |
All Payment Transactions
289 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $85.98 | General |
| Category: LIVER DISEASE | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GI | ||||||
| 10/31/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $173.35 | General |
| Category: Gastrointestinal AI | ||||||
| 10/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $3.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 699 | 747 | $487,635 | $74,844 |
| 2022 | 15 | 793 | 858 | $489,516 | $75,544 |
| 2021 | 15 | 1,012 | 1,082 | $594,932 | $93,797 |
| 2020 | 15 | 861 | 945 | $472,238 | $78,958 |
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 123 | 128 | $166,400 | $26,190 | 15.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 118 | 121 | $121,000 | $11,308 | 9.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 112 | 113 | $90,400 | $8,201 | 9.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 54 | $12,150 | $5,297 | 43.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 43 | 70 | $10,500 | $4,406 | 42.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 40 | 40 | $10,000 | $4,111 | 41.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $20,570 | $3,907 | 19.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 41 | 48 | $7,200 | $3,223 | 44.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $15,895 | $2,475 | 15.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $11,220 | $2,210 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,125 | $1,771 | 42.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 14 | 14 | $11,200 | $1,404 | 12.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 91 | 93 | $6,975 | $342.13 | 4.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 132 | 132 | $171,600 | $26,666 | 15.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 123 | 123 | $98,400 | $7,348 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 66 | $14,850 | $6,407 | 43.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 95 | 96 | $96,000 | $6,213 | 6.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 71 | 77 | $11,550 | $5,155 | 44.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 72 | $10,800 | $4,119 | 38.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 20 | 20 | $18,700 | $3,787 | 20.3% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 27 | 27 | $21,600 | $3,054 | 14.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 29 | $7,250 | $2,960 | 40.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,225 | $2,110 | 40.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 13 | 14 | $13,090 | $2,042 | 15.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $4,656 | $1,864 | 40.0% |
About Dr. Philip Trupiano, DO
Dr. Philip Trupiano, DO is a Gastroenterology healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073684361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Trupiano, DO has received a total of $5,373 in payments from pharmaceutical and medical device companies, with $1,851 received in 2024. These payments were reported across 289 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($5,273).
As a Medicare-enrolled provider, Trupiano has provided services to 3,365 Medicare beneficiaries, totaling 3,632 services with total Medicare billing of $323,144. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location East Greenwich, RI
- Active Since 11/10/2006
- Last Updated 11/05/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1073684361
Products in Payments
- RINVOQ (Biological) $825.59
- Humira (Biological) $501.20
- Creon (Drug) $427.15
- SKYRIZI (Biological) $368.02
- XIFAXAN (Drug) $319.44
- VOQUEZNA (Drug) $226.35
- LINZESS (Drug) $181.73
- GI GENIUS (Device) $173.35
- HUMIRA (Biological) $166.88
- ENTYVIO (Biological) $165.80
- DUPIXENT (Biological) $148.77
- Trulance (Drug) $142.67
- VIBERZI (Drug) $107.44
- IBSRELA (Drug) $106.97
- GENERAL GI DILATATION (Device) $100.00
- Linzess (Drug) $97.53
- ZEPOSIA (Drug) $86.34
- REZDIFFRA (Drug) $85.98
- ORISE (Device) $83.26
- CREON (Drug) $73.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in East Greenwich
Angela Fishman, D.o, D.O
Gastroenterology — Payments: $5,228
John Cribb, M.d, M.D
Gastroenterology — Payments: $5,173
Eric Berthiaume, M.d, M.D
Gastroenterology — Payments: $4,082
Dr. Pedro Barros, M.d, M.D
Gastroenterology — Payments: $3,296